All over the world, the manufacturers of pharmaceuticals are increasingly working and researching with highly potent active pharmaceutical ingredients (HPAPI). This paves the way for new therapies which make it possible to treat patients with lower doses at a simultaneously higher effectiveness of the active ingredients.
As a consequence, the demands on both the product and personnel safety also increase when producing pharmaceuticals. Of the utmost importance here is that the staff are reliably protected against accidental exposure to the active substances. This requirement for operator safety is ensured by means of a suitable containment concept.